AbCellera, provincial and fed governments announce $701M co-investment in local life sciences infrastructure

Province of B.C. chipping in $75 million, one of its largest biotech investments in history.

Vancouver’s life science sector received a massive boost Wednesday, as local biotech giant AbCellera announced a co-investment of $701 million to strengthen capabilities and infrastructure for drug development, manufacturing, and clinical research in Canada.

AbCellera CEO Carl Hansen made the announcement at the company’s facilities in Mount Pleasant. He…